Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2019 | 403 | 2.57 | Why? |
| Arthroplasty, Replacement, Knee | 7 | 2018 | 363 | 2.16 | Why? |
| Hip Fractures | 6 | 2019 | 667 | 1.38 | Why? |
| Osteoporotic Fractures | 3 | 2018 | 175 | 1.33 | Why? |
| Bone Density Conservation Agents | 6 | 2018 | 209 | 1.20 | Why? |
| Femoral Fractures | 3 | 2018 | 104 | 0.99 | Why? |
| Knee Joint | 4 | 2019 | 194 | 0.95 | Why? |
| Diphosphonates | 4 | 2018 | 121 | 0.90 | Why? |
| Osteoarthritis | 3 | 2018 | 205 | 0.87 | Why? |
| Fractures, Spontaneous | 2 | 2017 | 15 | 0.78 | Why? |
| Spain | 24 | 2021 | 15545 | 0.78 | Why? |
| Hip Joint | 2 | 2018 | 59 | 0.74 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.70 | Why? |
| Arthritis, Rheumatoid | 5 | 2021 | 2043 | 0.69 | Why? |
| Insurance, Health, Reimbursement | 1 | 2018 | 205 | 0.62 | Why? |
| Spondylitis, Ankylosing | 1 | 2018 | 231 | 0.60 | Why? |
| Hospital Costs | 1 | 2018 | 274 | 0.56 | Why? |
| Osteoporosis | 5 | 2017 | 410 | 0.56 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.54 | Why? |
| Accidents, Traffic | 1 | 2018 | 464 | 0.51 | Why? |
| Databases, Factual | 7 | 2021 | 6248 | 0.48 | Why? |
| Fractures, Bone | 2 | 2017 | 487 | 0.46 | Why? |
| Electronic Health Records | 4 | 2021 | 3492 | 0.46 | Why? |
| Homes for the Aged | 1 | 2021 | 1071 | 0.44 | Why? |
| State Medicine | 2 | 2021 | 2847 | 0.40 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2018 | 6166 | 0.39 | Why? |
| Bone Density | 5 | 2018 | 335 | 0.38 | Why? |
| Insulin | 2 | 2017 | 1316 | 0.38 | Why? |
| Antirheumatic Agents | 3 | 2021 | 3023 | 0.38 | Why? |
| Geranyltranstransferase | 2 | 2018 | 2 | 0.37 | Why? |
| Dimethylallyltranstransferase | 2 | 2018 | 3 | 0.37 | Why? |
| Farnesyltranstransferase | 2 | 2018 | 8 | 0.37 | Why? |
| Cohort Studies | 21 | 2021 | 36005 | 0.36 | Why? |
| Podiatry | 2 | 2018 | 30 | 0.35 | Why? |
| Foot Diseases | 2 | 2018 | 47 | 0.35 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.35 | Why? |
| Osteoarthritis, Knee | 3 | 2018 | 158 | 0.32 | Why? |
| Social Class | 1 | 2014 | 1360 | 0.31 | Why? |
| Biological Products | 2 | 2017 | 2331 | 0.30 | Why? |
| Spinal Fractures | 2 | 2017 | 124 | 0.30 | Why? |
| Bone and Bones | 2 | 2018 | 235 | 0.30 | Why? |
| Republic of Korea | 4 | 2021 | 5858 | 0.29 | Why? |
| Influenza, Human | 5 | 2021 | 10779 | 0.28 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.27 | Why? |
| Primary Health Care | 6 | 2021 | 4839 | 0.26 | Why? |
| Aged, 80 and over | 21 | 2021 | 88759 | 0.26 | Why? |
| Reoperation | 2 | 2017 | 544 | 0.25 | Why? |
| Aged | 35 | 2021 | 215776 | 0.24 | Why? |
| Elective Surgical Procedures | 1 | 2021 | 5338 | 0.24 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.24 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.22 | Why? |
| Female | 39 | 2021 | 380317 | 0.21 | Why? |
| Psychoses, Substance-Induced | 1 | 2021 | 91 | 0.21 | Why? |
| Middle Aged | 34 | 2021 | 270681 | 0.21 | Why? |
| Osteoarthritis, Hip | 2 | 2018 | 56 | 0.21 | Why? |
| Male | 36 | 2021 | 367725 | 0.21 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Viral Vaccines | 1 | 2021 | 7560 | 0.20 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.20 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.20 | Why? |
| Shoulder Dislocation | 1 | 2019 | 18 | 0.20 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.20 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.19 | Why? |
| Tibial Meniscus Injuries | 1 | 2018 | 6 | 0.19 | Why? |
| Forearm Injuries | 1 | 2017 | 5 | 0.18 | Why? |
| Anterior Cruciate Ligament Injuries | 1 | 2018 | 22 | 0.18 | Why? |
| Hospital Records | 1 | 2018 | 55 | 0.18 | Why? |
| Humeral Fractures | 1 | 2017 | 25 | 0.18 | Why? |
| Rib Fractures | 1 | 2017 | 26 | 0.18 | Why? |
| Gout | 1 | 2019 | 85 | 0.18 | Why? |
| Femur | 1 | 2018 | 100 | 0.18 | Why? |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2017 | 27 | 0.17 | Why? |
| Analgesics, Opioid | 2 | 2018 | 1070 | 0.17 | Why? |
| Densitometry | 1 | 2017 | 40 | 0.17 | Why? |
| Health Services Accessibility | 2 | 2021 | 10697 | 0.17 | Why? |
| Hip | 1 | 2017 | 29 | 0.17 | Why? |
| England | 3 | 2018 | 5116 | 0.17 | Why? |
| Humans | 49 | 2021 | 930598 | 0.17 | Why? |
| Time Factors | 6 | 2021 | 31397 | 0.16 | Why? |
| Sleep Deprivation | 1 | 2018 | 175 | 0.16 | Why? |
| Gaucher Disease | 1 | 2017 | 63 | 0.16 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.16 | Why? |
| Risk Factors | 16 | 2021 | 71621 | 0.16 | Why? |
| Foot | 1 | 2017 | 195 | 0.15 | Why? |
| United Kingdom | 7 | 2021 | 18046 | 0.15 | Why? |
| Incidence | 10 | 2019 | 25622 | 0.15 | Why? |
| Clinical Coding | 1 | 2017 | 172 | 0.15 | Why? |
| Prevalence | 8 | 2021 | 25773 | 0.15 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.15 | Why? |
| Connective Tissue Diseases | 1 | 2017 | 187 | 0.14 | Why? |
| Macular Degeneration | 1 | 2018 | 194 | 0.14 | Why? |
| Allografts | 1 | 2018 | 761 | 0.14 | Why? |
| Wales | 1 | 2017 | 758 | 0.14 | Why? |
| Registries | 4 | 2019 | 12327 | 0.14 | Why? |
| Hypoglycemic Agents | 2 | 2017 | 2165 | 0.14 | Why? |
| Arthritis | 1 | 2018 | 288 | 0.13 | Why? |
| Administration, Oral | 3 | 2018 | 2340 | 0.13 | Why? |
| Probability | 1 | 2018 | 923 | 0.13 | Why? |
| Age Distribution | 2 | 2021 | 3567 | 0.13 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.13 | Why? |
| United States | 7 | 2021 | 46150 | 0.13 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.13 | Why? |
| Surgical Wound Infection | 1 | 2019 | 501 | 0.13 | Why? |
| Analgesics | 1 | 2018 | 451 | 0.13 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.13 | Why? |
| Coronary Disease | 1 | 2019 | 645 | 0.13 | Why? |
| Safety | 1 | 2021 | 1583 | 0.12 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.12 | Why? |
| Waiting Lists | 1 | 2021 | 1388 | 0.12 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.12 | Why? |
| Suicidal Ideation | 1 | 2021 | 1226 | 0.12 | Why? |
| Propensity Score | 2 | 2018 | 2690 | 0.11 | Why? |
| Adult | 19 | 2021 | 244371 | 0.11 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.11 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.11 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.11 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.11 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.11 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.11 | Why? |
| Body Mass Index | 2 | 2021 | 4306 | 0.11 | Why? |
| Denmark | 2 | 2017 | 2654 | 0.11 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 1454 | 0.11 | Why? |
| Follow-Up Studies | 3 | 2019 | 17020 | 0.10 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.10 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.10 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.10 | Why? |
| Germany | 2 | 2021 | 9196 | 0.09 | Why? |
| Infant | 2 | 2021 | 30274 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Kidney Transplantation | 2 | 2018 | 5397 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 1510 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.08 | Why? |
| Sulfonylurea Compounds | 2 | 2017 | 79 | 0.08 | Why? |
| Regression Analysis | 1 | 2014 | 2484 | 0.08 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.08 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.08 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Stroke | 2 | 2019 | 8839 | 0.07 | Why? |
| France | 1 | 2021 | 12074 | 0.07 | Why? |
| Patient Compliance | 1 | 2014 | 1468 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.07 | Why? |
| Brain Ischemia | 1 | 2019 | 2813 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.06 | Why? |
| Child | 3 | 2021 | 70012 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Metformin | 2 | 2017 | 640 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2017 | 3209 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.05 | Why? |
| Area Under Curve | 2 | 2017 | 2564 | 0.05 | Why? |
| RANK Ligand | 1 | 2018 | 47 | 0.05 | Why? |
| Foot Orthoses | 1 | 2017 | 3 | 0.05 | Why? |
| Fractures, Stress | 1 | 2017 | 13 | 0.05 | Why? |
| Foot Ulcer | 1 | 2017 | 22 | 0.04 | Why? |
| Population Growth | 1 | 2017 | 37 | 0.04 | Why? |
| Alendronate | 1 | 2017 | 12 | 0.04 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2018 | 316 | 0.04 | Why? |
| Teriparatide | 1 | 2017 | 16 | 0.04 | Why? |
| Thiazolidinediones | 1 | 2017 | 70 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Angina, Unstable | 1 | 2018 | 110 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.04 | Why? |
| Denosumab | 1 | 2017 | 49 | 0.04 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2017 | 75 | 0.04 | Why? |
| Thiophenes | 1 | 2017 | 78 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Incretins | 1 | 2017 | 61 | 0.04 | Why? |
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 138 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.04 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.04 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.04 | Why? |
| Acetaminophen | 1 | 2018 | 326 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.04 | Why? |
| ROC Curve | 2 | 2017 | 6024 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.03 | Why? |
| Interrupted Time Series Analysis | 1 | 2017 | 868 | 0.03 | Why? |
| China | 1 | 2021 | 50654 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.03 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.03 | Why? |
| Carbamates | 1 | 2017 | 485 | 0.03 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.03 | Why? |
| Health Services Needs and Demand | 2 | 2018 | 3419 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2017 | 436 | 0.03 | Why? |
| Primary Prevention | 1 | 2019 | 778 | 0.03 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.03 | Why? |
| Demography | 1 | 2019 | 1660 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.03 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.03 | Why? |
| Standard of Care | 1 | 2017 | 1297 | 0.03 | Why? |
| Europe | 2 | 2017 | 12702 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.03 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.03 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.03 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.02 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.01 | Why? |
| Sepsis | 1 | 2019 | 3517 | 0.01 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.01 | Why? |
| Transplant Recipients | 1 | 2017 | 4982 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.01 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
Prieto-Alhambra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(237)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_